Citace podle APA (7th ed.)

Ennishi, D., Takata, K., Béguelin, W., Duns, G., Mottok, A., Farinha, P., . . . Steidl, C. (2019). Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition. Cancer discovery, 9(4), 546. https://doi.org/10.1158/2159-8290.CD-18-1090

Citace podle Chicago (17th ed.)

Ennishi, Daisuke, et al. "Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition." Cancer Discovery 9, no. 4 (2019): 546. https://doi.org/10.1158/2159-8290.CD-18-1090.

Citace podle MLA (9th ed.)

Ennishi, Daisuke, et al. "Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition." Cancer Discovery, vol. 9, no. 4, 2019, p. 546, https://doi.org/10.1158/2159-8290.CD-18-1090.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..